BCL2 and neoplasm: Mechanistically, IFN-γ directly acts on tumor cells to maintain survival (BCL2 and surviving expression) and stemness (55–57), decreases antigen presentation (58), enhances the expression of immunosuppressive molecules markedly ICBs and IDO (58–60), and leads to infiltration of tumor-associated neutrophil (46).